Latest Us Market News

Li-S Energy narrows its loss to $1.21 million in H1 2026, propelled by a $7.8 million ARENA grant and key manufacturing milestones including Australia’s first lithium metal foil production line. Strategic defence and aerospace partnerships bolster its commercialisation drive.

Medical Developments International (MVP) reported an 8% revenue increase driven by strong Penthrox growth, despite a slight EBIT loss impacted by foreign exchange. The company advances pediatric approvals and targets further volume gains.

Sonic Healthcare has reported a robust half-year performance, with revenue climbing 16.6% to A$5.45 billion and net profit rising 10.9%, underpinned by organic growth and key acquisitions. The company maintains its full-year guidance amid ongoing US business rationalisation.

Zip Co has delivered a standout half-year performance with record cash earnings and upgraded FY26 guidance, driven by strong US market momentum and innovative product launches.

Cyclopharm has achieved a key milestone with Technegas approved for clinical use at the US National Institutes of Health, marking a strategic advance in its American expansion. Installation is imminent, leveraging a federal procurement framework that could broaden Technegas applications beyond pulmonary embolism.

American West Metals has appointed a top Washington DC advisory firm to deepen US government engagement for its West Desert Project, aiming to establish the first domestic indium supply chain amid critical minerals supply risks.

Pengana International Equities reported a half-year net profit of $4.6 million, down from $26.9 million last year, while announcing an increased fully franked dividend and initiating a strategic review to address shareholder concerns.

Adherium Limited launches a A$7.52 million equity raising to fund commercial expansion of its Hailie SmartInhaler remote patient monitoring platform targeting asthma and COPD patients in the US. The company aims to scale patient numbers and progress towards value-based care contracts with major insurers.

Treasury Wine Estates reported a statutory loss driven by a significant US asset impairment but showed underlying growth in key markets. The company suspends its interim dividend and targets $100 million in annual cost savings through its TWE Ascent program.

Treasury Wine Estates reports a sharp 39.6% drop in earnings and a $649 million statutory loss due to a major US asset impairment, suspending dividends to preserve capital while advancing a $100 million cost-cutting transformation.

Treasury Wine Estates has reported a staggering $649.4 million net loss for the half year ending December 2025, driven by significant impairments on US assets and a drop in revenue. The company has suspended its interim dividend and unveiled a new Luxury-led operating model as it navigates these challenges.

Savana Asset Management highlights the US as the leading global equity market, driven by robust economic growth, AI investment surges, and investor-friendly policies. Their insights reveal why Australian investors might look across the Pacific for growth opportunities.